Cervical human papillomavirus infection and shedding of human immunodeficiency virus in cervicovaginal fluids: a cross-sectional study

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):78-82. doi: 10.1097/QAI.0b013e31826327a0.

Abstract

We evaluated the association between human papillomavirus cervical infection and HIV shedding in cervicovaginal lavage fluid (CVL), studying 89 HIV-infected women recruited at the Department of Infectious Diseases of Brescia (Italy). HIV shedding in CVL was found in a similar proportion of women with (30%; 21/70) and without (31.6%; 6/19) cervical human papillomavirus infection. A statistically significant correlation was found between HIV viral load in serum and CVL among the 27 women with detectable HIV in CVL (r = 0.4; P = 0.04). However, women on highly active antiretroviral therapy were more likely to have detectable HIV-RNA in CVL despite negative viremia (80% vs. 8%; P < 0.005).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Blood / virology
  • Body Fluids / virology*
  • Cervix Uteri / virology
  • Cross-Sectional Studies
  • Female
  • HIV / isolation & purification*
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • Humans
  • Italy
  • Middle Aged
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / virology*
  • Vagina / virology
  • Viral Load
  • Virus Shedding*
  • Young Adult

Substances

  • Anti-Retroviral Agents